Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent

Rajkumar Ramamoorthy1, Mahesh Radhakrishnan, Minasri Borah

  • 1Pharmacy Group, Birla Institute of Technology & Science, Faculty Division - III, Pilani, Rajasthan, India. rajkumarrna@yahoo.com

Behavioural Pharmacology
|January 16, 2008
PubMed

Insights

Ondansetron (OND), a 5-HT3 receptor antagonist, demonstrates antidepressant-like effects in behavioral tests. Chronic OND enhances other antidepressants and modulates anxiety-related behaviors, suggesting therapeutic potential.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Ondansetron (OND) is a 5-HT3 receptor antagonist primarily used for chemotherapy-induced nausea and emesis.
  • The role of 5-HT3 receptors in mood regulation and potential antidepressant effects of OND is not fully understood.

Purpose of the Study:

  • To investigate the antidepressant potential of ondansetron (OND) using established behavioral models in rodents.
  • To explore the interaction of OND with other antidepressant medications and its effects on anxiety-related behaviors.

Main Methods:

  • Acute and chronic treatments of OND were administered to mice and rats.
  • Behavioral assays included spontaneous locomotor activity, forced swim test, tail suspension test, open field test, and elevated plus maze.
  • Drug interaction studies were performed with fluoxetine, venlafaxine, desipramine, 8-hydroxy-2-(di-n-propylamino) tetralin, and paroxetine.

Main Results:

  • OND exhibited a biphasic, dose-dependent antidepressant-like effect, peaking at 0.1 microg/kg in forced swim and tail suspension tests.
  • Chronic OND pretreatment potentiated the antidepressant effects of fluoxetine and venlafaxine.
  • OND administration reversed hyperactivity and reduced anxiety-like behaviors in bulbectomized rats.

Conclusions:

  • Ondansetron displays antidepressant-like properties, potentially mediated via postsynaptic 5-HT3 receptors.
  • OND may enhance the efficacy of certain existing antidepressant drugs.
  • The findings suggest OND as a potential therapeutic agent for depression and anxiety disorders.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...